First American experienced a cyber incident that resulted in business disruption. The details of the incident were not provided, but it had an impact on the company’s operations. The full extent of the disruption is unclear, but it is evident that the incident had significant consequences for First American.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
